Table 1.
Summary of the SARS-CoV-2 3CLpro inhibition experiments by quinacrine and suramin.
| Molecule | IC50 (µM) | Inhibition Type |
|---|---|---|
| Quinacrine | 7.8 ± 0.6 | Competitive |
| Suramin | 6.3 ± 1.4 | Noncompetitive |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.